PharmGen Science, Inc. engages in the development and production of medicaments. It operates through the following business divisions: ETC Drug, OTC Drug, Obesity Drug and Health Food. The company was founded on August 22, 1966 and is headquartered in Hwaseong-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company